市場調査レポート

商品コード

1762497

ゴーシェ病治療の世界市場：市場規模・シェア・動向、業界分析 (種類別・治療法別・流通チャネル別・地域別)、将来予測 (2025年～2034年)

Gaucher Disease Treatment Market Size, Share, Trends, & Industry Analysis Report: By Type (Type 1, Type 3, Type 2), By Therapy, By Distribution Channel, and By Region - Market Forecast, 2025-2034

出版日: 2025年06月01日
発行: Polaris Market Research
ページ情報: 英文 129 Pages
納期: 即日から翌営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,250 627,555円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 775,215円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 922,875円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=147.66円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Polaris Market Research社の最新調査によると、世界のゴーシェ病治療の市場規模は2034年までに21億米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

ゴーシェ病は最も一般的なリポソーム貯蔵障害の一つで、脂肪化合物、特にグルコセレブロシドを分解する酵素であるグルコセレブロシダーゼの欠損によって引き起こされます。この酵素欠損はグルコセレブロシドの蓄積につながり、その結果、脾臓、肝臓、骨髄にゴーシェ細胞が形成されます。この疾患は主に、脾臓や肝臓の腫大、疲労、貧血、骨の不快感や骨折、出血などの症状を特徴とします。

稀な遺伝性疾患であるゴーシェ病の診断と治療は、この疾患に対する認識の高まりにより進化しています。認知度が高まったことで、より多くの人が早期に診断を受け、疾病管理の改善に繋がっています。啓発キャンペーン、スクリーニングの強化、医療専門家に対するトレーニングの強化がこの進歩を支えています。さらに、有病率の高い地域での新生児スクリーニングプログラムの拡大と優先順位付けは、早期発見と時宜を得た治療を大幅に改善しています。

ゴーシェ病治療市場はまた、米国食品医薬品局（FDA）からの医薬品承認数の増加によって牽引されており、主要市場プレーヤーが医薬品開発において革新的な戦略を採用するよう促しています。さらに、バイオ医薬品と研究機関の共同研究は、今後数年間で市場の成長を加速させると予想されます。

ゴーシェ病治療市場の競合は、大手企業がより新規で効果的な治療法の開発を常に模索していることを浮き彫りにしています。各社は、患者の予後改善に対する需要の高まりに応えるべく、治療法の進歩や既存治療法の代替法の探求に注力しています。

ゴーシェ病治療市場：分析概要

治療法別では、酵素補充療法が2024年の売上高シェア67.9%を占め、市場を独占しています。

種類別では、ゴーシェ病で最もよく発症するタイプである1型が患者数の増加により、2024年の売上高シェア75％で市場をリードしました。

北米は、ゴーシェ病に対する認知度の向上、医療インフラの強化、創薬・研究活動の活発化により、2024年の収益シェア47.4%で世界市場を独占しました。

アジア太平洋は予測期間中に最も速い成長を記録すると予想されます。同地域の堅調な成長は、医療インフラの改善と、希少疾患や生命を脅かす疾患に対する認識を高めるための政府の取り組みに起因しています。

ゴーシェ病治療市場の主要企業には、ファイザー社、ヤンセン・ファーマシューティカルズ社、JCRファーマシューティカルズ社、サノフィ・ジェンザイム社、武田薬品工業社、ジョンソン・エンド・ジョンソンサービス社、シャイアー・ヒューマン・ジェネティクス・セラピーズ社、エラド・セラピューティクス社などがあります。

市場スナップショット
ゴーシェ病治療の市場力学
- 促進要因と機会
  - 医療費の増加
  - 戦略的コラボレーション、買収、パートナーシップの強化
- 抑制要因と課題
  - 製造の初期コストが高め
PESTLE分析
ゴーシェ病治療市場の動向
バリューチェーン分析
COVID-19の影響分析

第5章世界のゴーシェ病治療市場：種類別

主な分析結果
イントロダクション
1型
3型
2型

第6章世界のゴーシェ病治療市場：治療法別

主な分析結果
イントロダクション
酵素補充療法（ERT）
基質還元療法（SRT）
その他

第7章世界のゴーシェ病治療市場：流通チャネル別

主な分析結果
イントロダクション
病院薬局
小売薬局
オンライン薬局

第8章世界のゴーシェ病治療市場：地域別

主な分析結果
イントロダクション
- ゴーシェ病治療市場の分析：地域別 (2020～2034年)
北米
- 北米：種類別（2020～2034年）
- 北米：治療法別（2020～2034年）
- 北米：流通チャネル別（2020～2034年）
- 米国
- カナダ
欧州
- 欧州：種類別（2020～2034年）
- 欧州：治療法別（2020～2034年）
- 欧州：流通チャネル別（2020～2034年）
- 英国
- フランス
- ドイツ
- イタリア
- スペイン
- オランダ
- ロシア
- その他欧州
アジア太平洋
- アジア太平洋：種類別（2020～2034年）
- アジア太平洋：治療法別（2020～2034年）
- アジア太平洋：流通チャネル別（2020～2034年）
- 中国
- インド
- マレーシア
- 日本
- インドネシア
- 韓国
- オーストラリア
- その他アジア太平洋
中東・アフリカ
- 中東・アフリカ：種類別（2020～2034年）
- 中東・アフリカ：治療法別（2020～2034年）
- 中東・アフリカ：流通チャネル別（2020～2034年）
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他中東・アフリカ
ラテンアメリカ
- ラテンアメリカ：種類別、2020-2034年
- ラテンアメリカ：治療法別（2020～2034年）
- ラテンアメリカ：流通チャネル別（2020～2034年）
- メキシコ
- ブラジル
- アルゼンチン
- その他ラテンアメリカ

第9章競合情勢

事業拡大・企業買収の分析
- 事業拡大
- 企業買収
提携/協業/合意/公開

第10章企業プロファイル

Amicus Therapeutics, Inc.
CANbridge Life Sciences Ltd.
Eli Lilly and Company
Johnson & Johnson, Inc.
Lingyi Biotechnology
Protalix Biotherapeutics Inc.
Sanofi
Spur Therapeutics
Takeda Pharmaceutical

図表

List of Tables:

Table 1 Global Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 2 Global Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 3 Global Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 4 North America: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 5 North America: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 6 North America: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 7 U.S.: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 8 U.S.: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 9 U.S.: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 10 Canada: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 11 Canada: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 12 Canada: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 13 Europe: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 14 Europe: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 15 Europe: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 16 UK: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 17 UK: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 18 UK: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 19 France: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 20 France: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 21 France: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 22 Germany: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 23 Germany: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 24 Germany: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 25 Italy: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 26 Italy: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 27 Italy: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 28 Spain: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 29 Spain: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 30 Spain: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 31 Netherlands: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 32 Netherlands: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 33 Netherlands: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 34 Russia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 35 Russia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 36 Russia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 37 Rest of Europe: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 38 Rest of Europe: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 39 Rest of Europe: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 40 Asia Pacific: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 41 Asia Pacific: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 42 Asia Pacific: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 43 China: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 44 China: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 45 China: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 46 India: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 47 India: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 48 India: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 49 Malaysia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 50 Malaysia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 51 Malaysia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 52 Japan: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 53 Japan: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 54 Japan: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 55 Indonesia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 56 Indonesia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 57 Indonesia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 58 South Korea: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 59 South Korea: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 60 South Korea: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 61 Australia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 62 Australia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 63 Australia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 64 Rest of Asia Pacific: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 65 Rest of Asia Pacific: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 66 Rest of Asia Pacific: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 67 Middle East & Africa: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 68 Middle East & Africa: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 69 Middle East & Africa: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 70 Saudi Arabia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 71 Saudi Arabia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 72 Saudi Arabia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 73 UAE: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 74 UAE: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 75 UAE: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 76 Israel: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 77 Israel: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 78 Israel: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 79 South Africa: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 80 South Africa: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 81 South Africa: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 82 Rest of Middle East & Africa: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 83 Rest of Middle East & Africa: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 84 Rest of Middle East & Africa: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 85 Latin America: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 86 Latin America: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 87 Latin America: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 88 Mexico: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 89 Mexico: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 90 Mexico: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 91 Brazil: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 92 Brazil: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 93 Brazil: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 94 Argentina: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 95 Argentina: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 96 Argentina: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 97 Rest of Latin America: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
Table 98 Rest of Latin America: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
Table 99 Rest of Latin America: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Gaucher Disease Treatment Market, 2020-2034 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Type
Figure 7. Global Gaucher Disease Treatment Market, by Type, 2024 & 2034 (USD Billion)
Figure 8. Market by Therapy
Figure 9. Global Gaucher Disease Treatment Market, by Therapy, 2024 & 2034 (USD Billion)
Figure 10. Market by Distribution Channel
Figure 11. Global Gaucher Disease Treatment Market, by Distribution Channel, 2024 & 2034 (USD Billion)
Figure 12. Global Gaucher Disease Treatment Market Assessment, By Geography, 2020-2034 (USD Billion)
Figure 13. Strategic Analysis - Global Gaucher Disease Treatment Market

Product Code: PM1514

The global Gaucher disease treatment market size is expected to reach USD 2.10 billion by 2034, according to a new study by Polaris Market Research. The report "Gaucher Disease Treatment Market Size, Share, Trends, Industry Analysis Report: By Therapy (Substrate Replacement Therapy, Enzyme Replacement Therapy, and Others), Type, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Gaucher disease is one of the most common liposomal storage disorders, caused by a deficiency of glucocerebrosidase, an enzyme responsible for breaking down fatty compounds, specifically glucocerebroside. This enzyme deficiency leads to the accumulation of glucocerebroside, resulting in the formation of Gaucher cells in the spleen, liver, and bone marrow. This condition is primarily characterized by symptoms such as an enlarged spleen or liver, fatigue, anemia, bone discomfort and fractures, and bleeding.

The diagnosis and treatment of Gaucher disease, a rare genetic disorder, are evolving due to increasing awareness of the condition. With greater awareness, more individuals are receiving earlier diagnoses, leading to improved disease management. Awareness campaigns, enhanced screening initiatives, and increased training for healthcare professionals support this progress. Additionally, the expansion and prioritization of newborn screening programs in regions with higher prevalence are significantly improving early identification and timely treatment.

The Gaucher disease treatment market is also driven by an increasing number of drug approvals from the US Food and Drug Administration (FDA), encouraging leading market players to adopt innovative strategies in drug development. Additionally, collaborations between biopharmaceutical and research institutions are expected to accelerate market growth in the coming years.

The competitive nature of the Gaucher disease treatment market highlights that leading players are constantly seeking to develop more novel and effective treatment alternatives. Companies are focused on advancing medical therapies and exploring alternatives to existing treatments, aiming to meet the growing demand for improved patient outcomes.

Key Highlights of Gaucher Disease Treatment Market Report

Based on therapy, the enzyme replacement therapy segment dominated the market with a 67.9% revenue share in 2024, driven by the high number of FDA-approved medications for the therapy.

By type, the Type 1 segment led the market with a 75% revenue share in 2024 due to a rise in patient occurrence, as this is the most commonly occurring type of Gaucher's disease.

North America dominated the global market with a 47.4% revenue share in 2024, driven by greater awareness of Gaucher disease, enhanced healthcare infrastructure, and increasing drug discovery and research activities.

Asia Pacific is expected to register the fastest growth during the forecast period. The region's robust growth is attributed to improved healthcare infrastructure and government efforts to raise awareness about rare and life-threatening diseases.

Key players in the Gaucher disease treatment market include Pfizer Inc.; Janssen Pharmaceuticals; JCR Pharmaceuticals Co Ltd.; Sanofi Genzyme; Takeda Pharmaceuticals; Johnson & Johnson Services, Inc.; Shire Human Genetics Therapies, Inc.; Erad Therapeutic Inc.; and ERAD Therapeutics.

Polaris Market Research has segmented the Gaucher disease treatment market report on the basis of therapy, type, and region:

Gaucher Disease Treatment Market Segmentation

By Therapy Outlook (Revenue - USD Billion, 2020-2034)

Substrate Replacement Therapy

Enzyme Replacement Therapy

Others

By Type Outlook (Revenue - USD Billion, 2020-2034)

Type 1

Type 2

Type 3

Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of the Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Gaucher Disease Treatment Market Report Scope

Report Attributes

Details

Market Size Value in 2024

USD 1.64 billion

Market Size Value in 2025

USD 1.67 billion

Revenue Forecast by 2034

USD 2.10 billion

CAGR

2.54% from 2025 to 2034

Base Year

2024

Historical Data

2020-2023

Forecast Period

2025-2034

Quantitative Units

Revenue in USD billion and CAGR from 2025 to 2034

Report Coverage

Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends

Segments Covered

By Therapy

By Type

Regional Scope

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Competitive Landscape

Gaucher Disease Treatment Industry Trends Analysis (2024)

Company profiles/industry participants profiling includes company overview, financial information, product/service benchmarking, and recent developments

Report Format

PDF + Excel

Customization

Report customization as per your requirements with respect to countries, regions, and segmentation.

For Specific Research Requirements

Request for Customized Report

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Gaucher Disease Treatment Market Insights

4.1. Gaucher Disease Treatment Market - Market Snapshot
4.2. Gaucher Disease Treatment Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Healthcare Spending
  - 4.2.1.2. Increasing Strategic Collaboration, Acquisition, and Partnership
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Initial Cost of Manufacturing
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Gaucher Disease Treatment Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Gaucher Disease Treatment Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
5.3. Type 1
- 5.3.1. Global Gaucher Disease Treatment Market, by Type 1, by Region, 2020-2034 (USD Billion)
5.4. Type 3
- 5.4.1. Global Gaucher Disease Treatment Market, by Type 3, by Region, 2020-2034 (USD Billion)
5.5. Type 2
- 5.5.1. Global Gaucher Disease Treatment Market, by Type 2, by Region, 2020-2034 (USD Billion)

6. Global Gaucher Disease Treatment Market, by Therapy

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
6.3. Enzyme Replacement Therapy (ERT)
- 6.3.1. Global Gaucher Disease Treatment Market, by Enzyme Replacement Therapy (ERT), by Region, 2020-2034 (USD Billion)
6.4. Substrate Reduction Therapy (SRT)
- 6.4.1. Global Gaucher Disease Treatment Market, by Substrate Reduction Therapy (SRT), by Region, 2020-2034 (USD Billion)
6.5. Others
- 6.5.1. Global Gaucher Disease Treatment Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Gaucher Disease Treatment Market, by Distribution Channel

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
7.3. Hospital Pharmacies
- 7.3.1. Global Gaucher Disease Treatment Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Billion)
7.4. Retail Pharmacies
- 7.4.1. Global Gaucher Disease Treatment Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)
7.5. Online Pharmacies
- 7.5.1. Global Gaucher Disease Treatment Market, by Online Pharmacies, by Region, 2020-2034 (USD Billion)

8. Global Gaucher Disease Treatment Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Gaucher Disease Treatment Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Gaucher Disease Treatment Market - North America
- 8.3.1. North America: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.3.3. North America: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.3.4. Gaucher Disease Treatment Market - U.S.
  - 8.3.4.1. U.S.: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.3.5. Gaucher Disease Treatment Market - Canada
  - 8.3.5.1. Canada: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
8.4. Gaucher Disease Treatment Market - Europe
- 8.4.1. Europe: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.4.3. Europe: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.4. Gaucher Disease Treatment Market - UK
  - 8.4.4.1. UK: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.5. Gaucher Disease Treatment Market - France
  - 8.4.5.1. France: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.6. Gaucher Disease Treatment Market - Germany
  - 8.4.6.1. Germany: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.7. Gaucher Disease Treatment Market - Italy
  - 8.4.7.1. Italy: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.8. Gaucher Disease Treatment Market - Spain
  - 8.4.8.1. Spain: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.9. Gaucher Disease Treatment Market - Netherlands
  - 8.4.9.1. Netherlands: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.10. Gaucher Disease Treatment Market - Russia
  - 8.4.10.1. Russia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.11. Gaucher Disease Treatment Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
8.5. Gaucher Disease Treatment Market - Asia Pacific
- 8.5.1. Asia Pacific: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.4. Gaucher Disease Treatment Market - China
  - 8.5.4.1. China: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.5. Gaucher Disease Treatment Market - India
  - 8.5.5.1. India: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.6. Gaucher Disease Treatment Market - Malaysia
  - 8.5.6.1. Malaysia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.7. Gaucher Disease Treatment Market - Japan
  - 8.5.7.1. Japan: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.8. Gaucher Disease Treatment Market - Indonesia
  - 8.5.8.1. Indonesia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.9. Gaucher Disease Treatment Market - South Korea
  - 8.5.9.1. South Korea: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.10. Gaucher Disease Treatment Market - Australia
  - 8.5.10.1. Australia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.11. Gaucher Disease Treatment Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
8.6. Gaucher Disease Treatment Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.4. Gaucher Disease Treatment Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.5. Gaucher Disease Treatment Market - UAE
  - 8.6.5.1. UAE: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.6. Gaucher Disease Treatment Market - Israel
  - 8.6.6.1. Israel: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.7. Gaucher Disease Treatment Market - South Africa
  - 8.6.7.1. South Africa: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.8. Gaucher Disease Treatment Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
8.7. Gaucher Disease Treatment Market - Latin America
- 8.7.1. Latin America: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.4. Gaucher Disease Treatment Market - Mexico
  - 8.7.4.1. Mexico: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.5. Gaucher Disease Treatment Market - Brazil
  - 8.7.5.1. Brazil: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.6. Gaucher Disease Treatment Market - Argentina
  - 8.7.6.1. Argentina: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.7. Gaucher Disease Treatment Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Amicus Therapeutics, Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. CANbridge Life Sciences Ltd.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Eli Lilly and Company
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Johnson & Johnson, Inc.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Lingyi Biotechnology
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Protalix Biotherapeutics Inc.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Sanofi
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Spur Therapeutics
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Takeda Pharmaceutical
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development

ゴーシェ病治療の世界市場：市場規模・シェア・動向、業界分析 (種類別・治療法別・流通チャネル別・地域別)、将来予測 (2025年～2034年)

Gaucher Disease Treatment Market Size, Share, Trends, & Industry Analysis Report: By Type (Type 1, Type 3, Type 2), By Therapy, By Distribution Channel, and By Region - Market Forecast, 2025-2034

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章分析手法

第4章世界のゴーシェ病治療市場の洞察

第5章世界のゴーシェ病治療市場：種類別

第6章世界のゴーシェ病治療市場：治療法別

第7章世界のゴーシェ病治療市場：流通チャネル別

第8章世界のゴーシェ病治療市場：地域別

第9章競合情勢

第10章企業プロファイル

List of Tables:

List of Figures:

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Gaucher Disease Treatment Market Insights

5. Global Gaucher Disease Treatment Market, by Type

6. Global Gaucher Disease Treatment Market, by Therapy

7. Global Gaucher Disease Treatment Market, by Distribution Channel

8. Global Gaucher Disease Treatment Market, by Geography

9. Competitive Landscape

10. Company Profiles

ゴーシェ病治療の世界市場：市場規模・シェア・動向、業界分析 (種類別・治療法別・流通チャネル別・地域別)、将来予測 (2025年～2034年)

Gaucher Disease Treatment Market Size, Share, Trends, & Industry Analysis Report: By Type (Type 1, Type 3, Type 2), By Therapy, By Distribution Channel, and By Region - Market Forecast, 2025-2034

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 分析手法

第4章 世界のゴーシェ病治療市場の洞察

第5章 世界のゴーシェ病治療市場：種類別

第6章 世界のゴーシェ病治療市場：治療法別

第7章 世界のゴーシェ病治療市場：流通チャネル別

第8章 世界のゴーシェ病治療市場：地域別

第9章 競合情勢

第10章 企業プロファイル

List of Tables:

List of Figures:

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Gaucher Disease Treatment Market Insights

5. Global Gaucher Disease Treatment Market, by Type

6. Global Gaucher Disease Treatment Market, by Therapy

7. Global Gaucher Disease Treatment Market, by Distribution Channel

8. Global Gaucher Disease Treatment Market, by Geography

9. Competitive Landscape

10. Company Profiles

第1章イントロダクション

第2章エグゼクティブサマリー

第3章分析手法

第4章世界のゴーシェ病治療市場の洞察

第5章世界のゴーシェ病治療市場：種類別

第6章世界のゴーシェ病治療市場：治療法別

第7章世界のゴーシェ病治療市場：流通チャネル別

第8章世界のゴーシェ病治療市場：地域別

第9章競合情勢

第10章企業プロファイル